Branko Cuglievan, MD, discusses data for revumenib in the pediatric R/R KMT2AR-acute leukemias subgroup from AUGMENT-101.
Branko Cuglievan, MD
Advertisement
Branko Cuglievan, MD, is an associate professor in the Department of Leukemia, associate professor in the Department of Pediatrics, and section chief of Department of Pediatrics Patient Care at The University of Texas MD Anderson Cancer Center.
Articles by Branko Cuglievan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
3
CARTITUDE-4 Analysis Shows Bridging Therapy Response Predicts Cilta-Cel Benefit in Lenalidomide-Refractory Myeloma
4
Topline LAGOON Results Show Missed OS End Point With Lurbinectedin in Relapsed SCLC
5